Story
Endorphins and endocannabinoids
Endorphins are peptides and endocannabinoids are lipids. Evidence on the runner's high and on pleasure from chili is unsettled, and evidence that CBD relieves pain, helps sleep or eases anxiety is limited.
Last updated
Overview and key questions
In short: The body can dampen pain by itself, and it uses more than one kind of molecule to do it.
Educational content, not medical advice. See a clinician about your own case.
Story path
Chapter 1
Two families the body makes itself
Endorphins are chains of amino acids, cut from a larger precursor molecule; this article is mainly about beta-. They belong to the opioid peptides, in the same family as enkephalins and dynorphins. These peptides act on opioid receptors, and a receptor is a protein on a cell that receives a signal. Opioid drugs act on this same system, and they carry risks of dependence and slowed breathing, so ask a doctor about any use of them. If someone has taken one and cannot be woken or is having trouble breathing, it may be an overdose. Do not wait even if the breathing has only become very slow: call your local emergency number right away.
Endocannabinoids are not peptides. They are lipids the body makes itself, and there are two main ones: anandamide (arachidonoyl ethanolamide) and 2-AG.
When you read a claim about a run, a spicy meal or a CBD advert, you can start with three questions: is it about a peptide or a lipid, was it measured in the blood or the brain, and who was the trial done in?
Mechanism · The opioid peptide family
The body's own opioid system has four receptors, the proteins on cells that receive these signals. Its peptides fall into four major families: beta-endorphin, enkephalins, dynorphins and nociceptin.
So endorphin is just one member of this family. Saying the opioid system is active does not mean endorphin is the one at work.
Mechanism · What endocannabinoids are
They bind cannabinoid receptors. The most abundant of these is CB1, which is plentiful in the brain; some cannabinoids also act on other receptors.
THC in cannabis also works through cannabinoid receptors, and it is the main ingredient behind cannabis's effects on mental state.
So the word cannabinoid can mean something the body makes or something from a plant. When you read it, first work out which one is meant.
Chapter 2
Endorphin in the blood and in the brain
It has two routes: from the pituitary, a gland just below the brain, into the blood, or along nerve fibers to areas of the brain. A rise in the blood after a run sounds like evidence for the endorphin high, yet no credible link has been established between blood levels and mood after exercise.
For what acts in the brain itself, there is a different line to follow. While pain signals travel up, the brain is also adjusting them from above: a descending pathway starts in the midbrain, passes through the medulla and reaches the spinal cord, where it can influence how pain signals are passed on. Some researchers have proposed that this line is sensitive to opioids. The pain-relieving action of opioids sits along the pain pathways, both peripheral and central, and one review especially stresses that it eases the distress pain brings.
Mechanism · The blood-brain barrier in between
This also explains why a blood draw struggles to answer questions about the brain directly. To see whether the brain's opioid system has moved, you need something like a brain scan.
Evidence · How much exercise raises blood levels
This comes from an older review. It is about blood levels and does not answer questions about release in the brain or about mood.
So saying endorphins came flooding out after one easy jog may not hold even at the blood step.
Chapter 3
A lipid signal made on demand
Signals usually pass from an upstream cell to a downstream one. This line runs the other way. The downstream cell releases molecules such as 2-AG, they land on CB1 receptors (proteins on cells that receive signals) on the upstream cell, and transmitter release falls. Researchers call this retrograde signaling, and the signal at that connection becomes weaker.
In animal experiments, signals of this kind also take part in the descending pain-relief line in the midbrain.
Mechanism · Made fresh versus stored ahead
Opioid peptides take a different route: they are first packed into vesicles in the cell body of the nerve cell, then carried down to the nerve endings. This is one more difference between the two kinds of signal.
Endocannabinoids are also hard to measure. They are fat-soluble and are cleared and distributed quickly, so small changes in the brain may not be measured accurately; this is a judgment from the discussion of a mouse paper.
Mechanism · Two molecules, two routes
So saying went up is not enough: it matters which one.
Evidence · Stress-induced pain relief in animals
One animal experiment looked at the kind that does not. Under stress, the periaqueductal gray of the midbrain quickly formed 2-AG and anandamide. Blocking CB1 receptors there made this pain relief disappear. Inhibiting the enzymes that break the molecules down made the pain relief stronger.
This study has no human data and cannot directly speak to pain relief in people. What it suggests is that, at least in animals, these lipid signals can suppress pain without going through opioids.
Chapter 4
Runner's high, chili and pain after exercise
The runner's high is just endorphins: this claim often leans on a rise in the blood, and a blood number cannot directly speak for the brain. Brain scans suggest the brain's opioid system changes after a 2-hour run. In a trial of 45 minutes of moderate running, the euphoria still appeared when opioid receptors were blocked. Endocannabinoids also rise in the blood, and cause in humans has not been proven for them either.
Exercise programs kept up for a while mostly bring small to moderate improvements in chronic pain, and the evidence is low quality. If pain persists and does not ease, see a doctor.
As for chili, the closest human trial only suggests that pain from capsaicin on the skin may be held down by the opioid system, and it measured pain, not pleasure.
Evidence · Both sides of the runner's high
One study gave 10 athletes this kind of PET scan. After 2 hours of running, binding fell in the prefrontal and limbic regions. The stronger the euphoria, the lower the binding. This supports a role for opioids in the brain but cannot prove they cause the euphoria.
Another study had 22 men, of whom 12 did high-intensity intervals. Afterward, binding also fell in frontal, limbic and other regions, yet this went along with more negative emotion. After 60 minutes of moderate exercise there was no overall change, though rising euphoria went along with falling binding. The study included only men and the sample was small. This suggests that opioid release in the brain cannot simply be equated with pleasure.
Now the side. In a double-blind trial of 63 people, 45 minutes of moderate running left people more euphoric and less anxious, with higher endocannabinoids in the blood. Blocking opioid receptors with a drug did not stop these changes. The authors call endocannabinoids a strong candidate, not a settled answer. This trial also measured the blood.
A systematic review of human work included 21 studies. After acute exercise, 14 of 17 studies measured a rise in anandamide, while results for 2-AG were inconsistent. Several studies found links between levels and features of the runner's high, but methodological obstacles mean cause in humans has still not been reliably proven.
In mice, pain relief and reduced anxiety after running depend on cannabinoid receptors, and a drug that blocks opioid receptors does not stop them. Euphoria itself cannot be measured in mice.
Evidence · How exercise and pain affect each other
This pain relief does not necessarily rely on opioids. In a double-blind trial of 58 healthy adults, pain fell after one handgrip session whether people took an opioid receptor blocker or a placebo. 2-AG rose in both conditions, while the rise in anandamide was blocked. This suggests opioids may not be the main system and that the two kinds of signal may interact. Participants averaged 21 years old, and the authors state this cannot be extended to people with chronic pain.
People with chronic pain respond less predictably, and the pain relief after exercise is often weaker: pain may fall, stay the same or sometimes rise. Feeling worse after exercise may make people less willing to move, and they may gradually move less.
Exercise programs kept up for a while are a separate matter. An overview of 21 Cochrane reviews found some benefit for pain and physical function, mostly small to moderate and inconsistent across reviews. The evidence was low quality, samples were small, and most follow-up lasted under a year. The side effect reported was mainly muscle soreness that eased within weeks, though only 25% of studies actively reported side effects.
So some pain when you first start is most often this kind of passing soreness, and it does not necessarily mean exercise is wrong for you. These are overall findings, not a treatment plan. If pain keeps getting worse or does not ease, see a doctor to find out why and adjust the amount of exercise together.
Myth · Chili releases a flood of endorphins
But this was applied to the skin, not eaten, and the study did not test whether eating chili works the same way. The sample was only 9 people, they rated pain rather than pleasure, and the paper's abstract does not mention .
The step that eating chili releases a flood of endorphins and brings pleasure has not been proven. There are other explanations for liking chili. A questionnaire study of 243 university students and a group of online respondents led its authors to propose that the body misreads the burn as danger, the person realizes it is actually safe, and this brings psychological pleasure. The authors treat this as only one of several possible mechanisms. The study measured no physiological markers and did not address endorphins, so it cannot prove this explanation or rule out endorphins.
For that pleasant feeling after a spicy meal, it is not yet clear which kind of signal is involved. Pain measured on the skin cannot answer a question about pleasure from eating. So chili can be enjoyed as a matter of taste, but no evidence supports using it to relieve pain or lift mood.
Chapter 5
CBD is not what the body makes
CBD itself does not make people intoxicated; the main ingredient that affects mental state is THC, though commercial products may contain THC.
The impression that CBD cures everything is far from what has been approved. The prescription CBD medicine approved by the US FDA is used only for seizures linked to a few rare, severe forms of epilepsy.
When you see an advert saying CBD relieves pain or helps sleep, you can ask: who was the trial done in, and was it this kind of product? People taking medicines should ask a doctor or pharmacist before buying CBD. During pregnancy and breastfeeding, the US FDA advises avoiding CBD, THC and cannabis in any form. If pain persists, sleep stays poor for a long time or anxiety disrupts your life, see a doctor first to find out why rather than testing CBD on your own.
Evidence · Pain, anxiety and sleep
Then anxiety and sleep. A systematic review pooled 54 randomized trials with 2477 people, all patients with mental health or substance use problems. Treatments included CBD alone as well as THC and the two combined, so this is not ordinary people taking CBD.
Outcomes related to anxiety showed no significant effect, which does not prove it fails. Patients with insomnia did sleep longer, and the evidence across the review was mostly low quality. Adverse events were more common overall, while serious adverse events did not increase.
Guidance from a US health agency also says it is uncertain whether these products help people without other illnesses to sleep. When patients sleep better, it is also unclear whether the product worked directly or their symptoms improved. For anxiety, only a small amount of human evidence suggests it might help, and the one study whose size is stated had just 24 people and tested a simulated public speech.
So the pain relief, better sleep and calmer nerves in the adverts are not yet backed by the trials so far. The review's authors also say that routine use of cannabinoids for these mental health and substance use problems is rarely justified at present.
Numbers · Labels are often inaccurate
As for contaminants, heavy metals were found in 44 products, residual solvents in 181 and pesticides in 30. Most products had little or no contamination. Only a minority exceeded regulatory limits: about 3% for lead, and about 1% to 9% for solvents and pesticides depending on the standard.
This study did not sample at random and tested only one sample per product. It was funded by a company that sells prescription CBD medicine, and the funder took part in the design and writing. The numbers are laboratory measurements, and the paper says they agree with other independent studies.
So the amount printed on the bottle cannot simply be taken at face value.
Safety · Liver, medicines and THC
The rises appeared only after 3 weeks or later, returned to pre-treatment levels within 1 to 2 weeks of stopping and caused no clinically meaningful change in liver function. Thyroid and male reproductive hormones did not differ; even so, a US health agency's fact sheet links CBD to male reproductive harm, and what longer use does is not known. Participants were healthy people with no other illnesses who took no other medicines, and a one-month trial cannot speak to long-term effects. The authors think the risk in the general population may be higher. The drug was stopped as soon as enzymes rose, so what would happen with continued use is not known. This does not mean CBD simply damages the liver, and it does not mean raised liver enzymes are nothing to think about.
On interactions, one review lists antiepileptic drugs, antidepressants, opioid painkillers and THC, and also covers acetaminophen and alcohol. Many of these are predicted from laboratory and animal data, and human data are scarce. Because so little is known, people taking medicines should ask a doctor or pharmacist before buying CBD.
Cannabis and products containing THC carry separate risks, including motor vehicle crashes and cannabis use disorder, which adolescents are more likely to develop. People who are predisposed also face a risk of psychosis. Laws vary by place.
References (19)
- Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Walker, J. M., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2005). An endocannabinoid mechanism for stress-induced analgesia. Nature, 435(7045), 1108-1112. 10.1038/nature03658
- Corder, G., Castro, D. C., Bruchas, M. R., & Scherrer, G. (2018). Endogenous and exogenous opioids in pain. Annual Review of Neuroscience, 41, 453-473. 10.1146/annurev-neuro-080317-061522
- Lu, H. C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological Psychiatry, 79(7), 516-525. 10.1016/j.biopsych.2015.07.028
- Goldfarb, A. H., & Jamurtas, A. Z. (1997). Beta-endorphin response to exercise. An update. Sports Medicine, 24(1), 8-16. 10.2165/00007256-199724010-00002
- World Health Organization. (2025, August 29). Opioid overdose. www.who.int/news-room/fact-sheets/detail/opioid-overdose
- Fuss, J., Steinle, J., Bindila, L., Auer, M. K., Kirchherr, H., Lutz, B., & Gass, P. (2015). A runner's high depends on cannabinoid receptors in mice. Proceedings of the National Academy of Sciences, 112(42), 13105-13108. 10.1073/pnas.1514996112
- Saanijoki, T., Tuominen, L., Tuulari, J. J., Nummenmaa, L., Arponen, E., Kalliokoski, K., & Hirvonen, J. (2018). Opioid release after high-intensity interval training in healthy human subjects. Neuropsychopharmacology, 43(2), 246-254. 10.1038/npp.2017.148
- Ossipov, M. H., Dussor, G. O., & Porreca, F. (2010). Central modulation of pain. Journal of Clinical Investigation, 120(11), 3779-3787. 10.1172/JCI43766
- Siebers, M., Biedermann, S. V., & Fuss, J. (2023). Do endocannabinoids cause the runner's high? Evidence and open questions. The Neuroscientist, 29(3), 352-369. 10.1177/10738584211069981
- Rice, D., Nijs, J., Kosek, E., Wideman, T., Hasenbring, M. I., Koltyn, K., Graven-Nielsen, T., & Polli, A. (2019). Exercise-induced hypoalgesia in pain-free and chronic pain populations: State of the art and future directions. The Journal of Pain, 20(11), 1249-1266. 10.1016/j.jpain.2019.03.005
- Anderson, W. S., Sheth, R. N., Bencherif, B., Frost, J. J., & Campbell, J. N. (2002). Naloxone increases pain induced by topical capsaicin in healthy human volunteers. Pain, 99(1-2), 207-216. 10.1016/s0304-3959(02)00103-3
- Rozin, P., Guillot, L., Fincher, K., Rozin, A., & Tsukayama, E. (2013). Glad to be sad, and other examples of benign masochism. Judgment and Decision Making, 8(4), 439-447. 10.1017/S1930297500005295
- Boecker, H., Sprenger, T., Spilker, M. E., Henriksen, G., Koppenhoefer, M., Wagner, K. J., Valet, M., Berthele, A., & Tolle, T. R. (2008). The runner's high: opioidergic mechanisms in the human brain. Cerebral Cortex, 18(11), 2523-2531. 10.1093/cercor/bhn013
- Siebers, M., Biedermann, S. V., Bindila, L., Lutz, B., & Fuss, J. (2021). Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. Psychoneuroendocrinology, 126, 105173. 10.1016/j.psyneuen.2021.105173
- Geneen, L. J., Moore, R. A., Clarke, C., Martin, D., Colvin, L. A., & Smith, B. H. (2017). Physical activity and exercise for chronic pain in adults: An overview of Cochrane Reviews. Cochrane Database of Systematic Reviews, 4(4), CD011279. 10.1002/14651858.CD011279.pub3
- Balachandran, P., Elsohly, M., & Hill, K. P. (2021). Cannabidiol interactions with medications, illicit substances, and alcohol: A comprehensive review. Journal of General Internal Medicine, 36(7), 2074-2084. 10.1007/s11606-020-06504-8
- Moore, A., Straube, S., Fisher, E., & Eccleston, C. (2024). Cannabidiol (CBD) products for pain: Ineffective, expensive, and with potential harms. The Journal of Pain, 25(4), 833-842. 10.1016/j.jpain.2023.10.009
- National Center for Complementary and Integrative Health. (2019, November). Cannabis (marijuana) and cannabinoids: What you need to know. www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
- U.S. Food and Drug Administration. (2019). What you should know about using cannabis, including CBD, when pregnant or breastfeeding (Consumer update, content current as of 16 October 2019). www.fda.gov/consumers/consumer-updates/what-you-should-know-about-using-cannabis-including-cbd-when-pregnant-or-breastfeeding
Written from the sources listed above. Checked sentence by sentence against them in . No physician reviews this site: it explains how the body works, and it is not medical advice. How we make content
Spotted an error, or something unclear? Email us. We read every message, check it against the sources, and fix what's wrong.